Literature DB >> 1277442

Immediate (type I) allergic responses to platinum compounds.

M J Cleare, E G Hughes, B Jacoby, J Pepys.   

Abstract

A series of platinum complexes has been used for allergy tests in a number of platinum refinery workers who are known to be sensitive to hexachloroplatinate ([PtCl6]2-) salts. The results show that the allergy-eliciting compounds are confined to a very small group of ionic complexes containing reactive halogen ligands. Neutral complexes and those containing more strongly bound ligands are totally inactive. These variations in activity are interpreted in terms of established kinetic and thermodynamic parameters.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277442     DOI: 10.1111/j.1365-2222.1976.tb01897.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  23 in total

1.  Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer.

Authors:  M Fukuda; T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; A Kojima; F Oshita; K Hara; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  20 years of medical surveillance on exposure to allergenic and non-allergenic platinum compounds: the importance of chemical speciation.

Authors:  P J Linnett; E G Hughes
Journal:  Occup Environ Med       Date:  1999-03       Impact factor: 4.402

Review 3.  Hypersensitivity reactions from antineoplastic agents.

Authors:  R B Weiss; J R Baker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Hypersensitivity reactions to carboplatin in children.

Authors:  Ilaria Lazzareschi; Antonio Ruggiero; Riccardo Riccardi; Giorgio Attinà; Cesare Colosimo; Anna Lasorella
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

5.  Hypersensitivity reactions to carboplatin and cisplatin in non-small cell lung cancer.

Authors:  J Michael Randall; Anjali A Bharne; Lyudmila A Bazhenova
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

6.  The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment.

Authors:  Roisin O'Cearbhaill; Qin Zhou; Alexia Iasonos; Martee L Hensley; William P Tew; Carol Aghajanian; David R Spriggs; Stuart M Lichtman; Paul J Sabbatini
Journal:  Gynecol Oncol       Date:  2009-11-27       Impact factor: 5.482

7.  Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer.

Authors:  H I Scher; D Kelsen; L Kalman; L Jones; J Burchenal; R Gralla
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  Application of the direct peptide reactivity assay (DPRA) to inorganic compounds: a case study of platinum species.

Authors:  Jocelyn D C Hemming; Mark Hosford; Martin M Shafer
Journal:  Toxicol Res (Camb)       Date:  2019-11-20       Impact factor: 3.524

9.  Immunological responses to complex salts of platinum. II. Enhanced IgE antibody responses to ovalbumin with concurrent administration of platinum salts in the rat.

Authors:  R D Murdoch; J Pepys
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

10.  Quantitative skin prick and bronchial provocation tests with platinum salt.

Authors:  R Merget; G Schultze-Werninghaus; F Bode; E M Bergmann; W Zachgo; J Meier-Sydow
Journal:  Br J Ind Med       Date:  1991-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.